Reinsurance Group of America (FRA:RGPB) Research & Development: €0 Mil (TTM As of Mar. 2026)


FRA:RGPB Reinsurance Group of America Inc FRA:RGPB
83 GF Score
Price €191.00
GF Value €205.55
! 4 Warning Signs
View Full Analysis

What is Reinsurance Group of America Research & Development?

Reinsurance Group of America FRA:RGPB +2.25% 83 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates FRA:RGPB with a GF Score™ of 83/100 and a GF Value™ of €205.55. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Reinsurance Group of America's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Reinsurance Group of America  (FRA:RGPB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Reinsurance Group of America Research & Development Related Terms

Reinsurance Group of America Research & Development Historical Data

* Premium members only.

The historical data trend for Reinsurance Group of America's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reinsurance Group of America Research & Development Chart

Reinsurance Group of America Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Reinsurance Group of America Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:RGPB
83GF Score
Reinsurance Group of America Inc FRA:RGPB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reinsurance Group of America Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Reinsurance Group of America (FRA:RGPB) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Reinsurance Group of America and its competitors.
Is Reinsurance Group of America's Research & Development too high?
Reinsurance Group of America's current Research & Development is €0 Mil. Overall, Reinsurance Group of America has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Reinsurance Group of America's Research & Development compare to EG and RNR?
Reinsurance Group of America's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Reinsurance Group of America and its competitors. Reinsurance Group of America's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reinsurance Group of America stock overvalued right now?
Reinsurance Group of America (FRA:RGPB) has a current Research & Development of €0 Mil. The stock's GF Value™ is €205.55, compared to a current price of €191.00 — trading 7.1% below its estimated fair value. The current Research & Development is €0 Mil. Reinsurance Group of America's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Reinsurance Group of America (FRA:RGPB), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Reinsurance Group of America (FRA:RGPB) Overvalued in 2026?

Based on GuruFocus' analysis, Reinsurance Group of America stock appears to be undervalued. The current stock price of €191.00 is trading 7.1% below its estimated GF Value™ of €205.55.

Key valuation signals for FRA:RGPB:

  • Research & Development: €0 Mil
  • GF Value™: €205.55 vs. price of €191.00 (7.1% below fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the FRA:RGPB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Reinsurance Group of America Business Description

Other Exchanges RGA:USA
Address 16600 Swingley Ridge Road, Chesterfield, MO, USA, 63017
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
83GF Score

Get the complete analysis for FRA:RGPB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€191.00
Price
€205.55
GF Value